Linklaters has advised BNP Paribas, Deutsche Bank and J.P. Morgan on the bridge loan financing for Merck KGaA, supporting its proposed acquisition of Bio-Techne Corporation (NASDAQ: TECH) at a total enterprise value of approximately US$11.3bn.
The international cross-practice Linklaters team was led by Marc Trinkaus(Partner) and Urs Lewens (Counsel) (both Banking, Frankfurt).
Further team members were New York Partners Gregory Gewirtz (Corporate M&A), Philip Lee (Banking), Michelle Lo (Tax), Counsels Ulrich Johann (Tax, Frankfurt), Omer Harel (Tax), Senior Associates David Mba (Corporate M&A), Reuven Rosen (Tax, all NY), Managing Associate Alexandra Selezneva(Banking, Düsseldorf), as well as Associates Matthias Horváth (Banking) and Benedikt Kruse (Tax, both Frankfurt).
Linklaters is a market leader in syndicated lending, acquisition finance, and financing in the context of spinoff and other corporate reorganisations. The team have advised, amongst others, Continental on a €2.5bn syndicated credit facility for AUMOVIO in connection with the spin-off of the automotive segment as AUMOVIO group, E.ON SE in relation to a syndicated credit facility in the amount of €4.7bn and Bayer AG on a syndicated credit facility in the amount of €5bn.
Where the legal industry reads first.
Enjoyed this article? Get the biggest legal industry updates, deals, appointments, insights and expert interviews in your inbox, free.
No spam. Unsubscribe anytime.From Legal Desire
Is your firm the one being cited, or the one being skipped?
We ran the test. On several everyday legal questions, software companies are answering and law firms are not. We help firms fix that, and we build the technology behind the practice.
